S100A8 and S100A9 in Cancer
Y Chen, Y Ouyang, Z Li, X Wang, J Ma - Biochimica et Biophysica Acta …, 2023 - Elsevier
Abstract S100A8 and S100A9 are Ca 2+ binding proteins that belong to the S100 family.
Primarily expressed in neutrophils and monocytes, S100A8 and S100A9 play critical roles in …
Primarily expressed in neutrophils and monocytes, S100A8 and S100A9 play critical roles in …
[HTML][HTML] Targeting MERTK and AXL in EGFR Mutant Non-Small Cell Lung Cancer
D Yan, HS Earp, D DeRyckere, DK Graham - Cancers, 2021 - mdpi.com
Simple Summary Expression of MERTK and/or AXL (members of the TAM family of receptor
tyrosine kinases) provides a survival advantage for non-small cell lung cancer (NSCLC) …
tyrosine kinases) provides a survival advantage for non-small cell lung cancer (NSCLC) …
[HTML][HTML] Drug repositioning in non-small cell lung cancer (NSCLC) using gene co-expression and drug–gene interaction networks analysis
H MotieGhader, P Tabrizi-Nezhadi… - Scientific Reports, 2022 - nature.com
Lung cancer is the most common cancer in men and women. This cancer is divided into two
main types, namely non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) …
main types, namely non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) …
[HTML][HTML] Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer
M Bao, Y Huang, Z Lang, H Zhao, Y Saito… - … lung cancer research, 2022 - ncbi.nlm.nih.gov
Background Currently, the prognosis of patients with non-small cell lung cancer (NSCLC)
remains unsatisfactory. This current study evaluated the relationship between histology of …
remains unsatisfactory. This current study evaluated the relationship between histology of …
Applications of machine learning to predict cisplatin resistance in lung cancer
Y Gao, Q Lyu, P Luo, M Li, R Zhou… - International journal of …, 2021 - Taylor & Francis
Purpose Lung cancer, mainly lung adenocarcinoma, lung squamous cell carcinoma and
small cell lung cancer, has the highest incidence and cancer-related mortality worldwide …
small cell lung cancer, has the highest incidence and cancer-related mortality worldwide …
[HTML][HTML] FNDC3B and BPGM are involved in human papillomavirus-mediated carcinogenesis of cervical cancer
L Zhang, H Yu, T Deng, L Ling, J Wen, M Lv… - Frontiers in …, 2021 - frontiersin.org
Human papillomavirus (HPV)-mediated cervical carcinogenesis is a multistep progressing
from persistent infection, precancerous lesion to cervical cancer (CCa). Although molecular …
from persistent infection, precancerous lesion to cervical cancer (CCa). Although molecular …
[HTML][HTML] Identification of crucial lncRNAs and mRNAs in liver regeneration after portal vein ligation through weighted gene correlation network analysis
Y Zhu, Z Li, J Zhang, M Liu, X Jiang, B Li - BMC genomics, 2022 - Springer
Background Portal vein ligation (PVL)-induced liver hypertrophy increases future liver
remnant (FLR) volume and improves resectability of large hepatic carcinoma. However, the …
remnant (FLR) volume and improves resectability of large hepatic carcinoma. However, the …
Tumor-associated Macrophages Mediate Gefitinib Resistance in Lung Cancer through HGF/c-met Signaling Pathway
X Tang, Y Chen, D Jiao, X Liu, J Chen… - Anti-Cancer Agents …, 2024 - ingentaconnect.com
Background: The biological behavior of cells changes after they develop drug resistance,
and the degree of resistance will be affected by the tumor microenvironment. In this study …
and the degree of resistance will be affected by the tumor microenvironment. In this study …
[HTML][HTML] Identification of gefitinib resistance-related lncRNA-miRNA-mRNA regulatory networks and corresponding prognostic signature in patients with lung …
T Wang, Z Wu, S Li, Z Chen, Y Chen… - International Journal of …, 2022 - ncbi.nlm.nih.gov
Purpose To identify and characterize gefitinib resistance-related (GefR-related) lncRNAs
and construct a prediction model for lung adenocarcinoma (LUAD). Methods Differential …
and construct a prediction model for lung adenocarcinoma (LUAD). Methods Differential …
[HTML][HTML] Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
Y Yu - Cancer Biology & Medicine, 2021 - ncbi.nlm.nih.gov
Glucocorticoids are drugs that are controversial in the treatment of malignant tumors,
especially in regimens using immune checkpoint inhibitors. Some oncologists warn that …
especially in regimens using immune checkpoint inhibitors. Some oncologists warn that …